John Kilhefner

John Kilhefner

Senior Managing Editor, Lango Franchise

John Kilhefner is Senior Managing Editor of the Luke Lango franchise, which includes Hypergrowth Investing, Innovation Investor, Crypto Investor Network, and more.
Kilhefner has contributed to media such as Benzinga, The Hill, Tip Ranks, Unwinnable, The Arcade Review, Five Out of Ten magazine, and ZAM. He has appeared in U.S. News and World Report, Kotaku, USA Today, and Game Developer.
He now runs his own creative agency focused on tech and cybersecurity, called Skellator, LLC.
Learn more here

Recent Articles

Wells Fargo & Co: The Pain Is Just Beginning for WFC

By John Kilhefner, Senior Managing Editor, Lango Franchise

Wells Fargo stock (WFC) is going to see things get worse, as state governments, law firms and politicians are only getting started.

Dynavax Technologies Corporation (DVAX) Steals Back Gains on Pending Heplisav Treatment

By John Kilhefner, Senior Managing Editor, Lango Franchise

Dynavax Technologies (DVAX) is surging on news that the FDA is moving closer to approving Heplisav in time for its PDUFA date.

Aurinia Pharmaceuticals Inc (AUPH) Makes Comeback on Encouraging Trial Data

By John Kilhefner, Senior Managing Editor, Lango Franchise

Aurinia Pharmaceuticals Inc (AUPH) is clawing back to its pre-voclosporin-folly levels after its treatment met endpoint goals without a hitch.

Restoration Hardware Holdings Inc (RH) Pops on Williams-Sonoma, Inc. (WSM) Buyout Chatter

By John Kilhefner, Senior Managing Editor, Lango Franchise

Restoration Hardware Holdings Inc (RH) is up on news that Williams-Sonoma, Inc. (WSM) may buy. Is that a wise move, or a desperate one?

Priceline Group Inc Is Going to Break $1,500! (PCLN)

By John Kilhefner, Senior Managing Editor, Lango Franchise

Priceline Group Inc (NASDAQ:PCLN) is growing earnings faster than its stock price, but competitors and industry challenges could hinder it.

Anavex Life Sciences Corp. (AVXL) Scores Big on Biogen Test

By John Kilhefner, Senior Managing Editor, Lango Franchise

Anavex (AVXL) stock is up more than 40% after Biogen (BIIB) announced it would test one of its compounds, but AVXL is still in the red for the year.

Tempur Sealy International Inc (TPX) Hits the Mat on Dismal Sales Forecast

By John Kilhefner, Senior Managing Editor, Lango Franchise

Tempur Sealy International Inc (TPX) is taking a 22% nosedive after revealing it expects a sales decline for the full year.

Kite Pharma Inc Scores Big on Positive Clinical Trial (KITE)

By John Kilhefner, Senior Managing Editor, Lango Franchise

Kite Pharma Inc (NASDAQ:KITE) and Juno Therapeutics (NASDAQ:JUNO) are both riding high on KITE's positive lymphoma therapy results. Here's what happened.

GoPro Inc (GPRO) Tanks on Mavic Pro Drone From DJI

By John Kilhefner, Senior Managing Editor, Lango Franchise

GoPro Inc (GPRO) is going to need a new gamechanger if the competitively priced Mavic Pro is as far ahead in hardware and software as the reviews suggest.

American Express Company (AXP) Hikes Dividend, Buys Back More Stock

By John Kilhefner, Senior Managing Editor, Lango Franchise

American Express (AXP) stock is up Tuesday after announcing a new share buyback plan and 10% dividend increase. Here's what you should know.

Load More